Johnson & Johnson is reportedly looking for opportunities to merge with or acquire other companies as they seep to add value to it’s focus market areas of eye care, surgical robots, orthopedics and cardiovascular products.
Johnson & Johnson Chief Executive Officer Joaquin Duato said on Monday that the company is in the process of spinning off its consumer healthcare business under the brand Kenvue to focus on its pharmaceutical and medical devices interests.
“We’ll continue to be disciplined in looking for opportunities in which we can create value that serve a significant unmet medical need like heart failure,” Duato said at the J.P. Morgan Healthcare Conference (h/t Yahoo Finance).
Duato said many of its future deals would likely be small “tuck-in” acquisitions.
